Concepedia

Author

Juliana Ianus

Janssen (United States)

Also Known As

Ianus, Juliana, J. Ianus, JULIANA IANUS, Juliana Ianus

22

Publications

2.8K

Citations

8

H-Index

4

Concepts

All Affiliations

Janssen (United States)Rotterdam University of Applied SciencesBayer (Germany)
JI

About

Juliana Ianus is an author at Janssen (United States) specializing in virology, clinical outcomes, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

13

2

Clinical Outcomes

1

1

13

3

Infection Control

1

1

13

4

Virology

1

1

13

Juliana Ianus

×

8

Publications

2.8K

Citations

8

H-Index

YearCitations

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode,

New England Journal of Medicine

2016

1.5K

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla,

Journal of Clinical Oncology

2003

770

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Gary J. Noel, Karen Bush, Partha Bagchi,

Clinical Infectious Diseases

2008

267

Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT<sub>3</sub> antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin

Richard J. Gralla, Ronald de Wit, Alexandra D. Carides,

Cancer

2005

91

Efficacy and Safety of a Neurokinin-1 Receptor Antagonist in Postmenopausal Women With Overactive Bladder With Urge Urinary Incontinence

Stuart A. Green, Achilles Alon, Juliana Ianus,

The Journal of Urology

2006

91

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding

Jeffrey A. Kline, David Jiménez, D. Mark Courtney,

Academic Emergency Medicine

2016

27

Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial

Mintu P. Turakhia, Vandana Sundaram, Shea N. Smith,

American Heart Journal

2021

19

A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection

Anna Nilsson, John Pullman, Piotr Napora,

Clinical Microbiology and Infection

2023

13

Page 1